Methyl 6-bromoisoquinoline-1-carboxylate

Catalog No.: 
ACRFOM917
CAS No.: 
1521757-08-3
Molecular Formula: 
C11H8BrNO2
Molecular Weight: 
266.09
Methyl 6-bromoisoquinoline-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$196.00InquiryInquiry
250mg95%$314.00InquiryInquiry
1g95%$780.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 6-bromoisoquinoline-1-carboxylate
IUPAC Namemethyl 6-bromoisoquinoline-1-carboxylate
MDL No.MFCD22097455
Molecular FormulaC11H8BrNO2
Molecular Weight266.09
SMILESO=C(OC)C1C2C=CC(=CC=2C=CN=1)Br
InChI KeyGJWYZNSAVAKZQQ-UHFFFAOYSA-N
SynonymMethyl 6-bromoisoquinoline-1-carboxylate;6-Bromo-isoquinoline-1-carboxylic acid methyl ester;1-Isoquinolinecarboxylic acid, 6-bromo-, methyl ester
CAS No.1521757-08-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACRFOM917 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. ACGMVA039 route compound structure diagram
    ACGMVA0391256806-36-6In Stock
  4. Then
  5. ACRFOM917 route product structure diagram
    ACRFOM9171521757-08-3
Inquiry

2. ACRFOM917 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACGMVA039 route compound structure diagram
    ACGMVA0391256806-36-6In Stock
  4. Then
  5. ACRFOM917 route product structure diagram
    ACRFOM9171521757-08-3
Inquiry

3. ACRFOM917 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRFOM917 route product structure diagram
    ACRFOM9171521757-08-3
Inquiry

Comments (0)